Atlas Trials

Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma

Clinical trial NCT03884998 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03884998
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular LymphomaIndolent Non-Hodgkin LymphomaLymphoplasmacytic LymphomaMarginal Zone LymphomaRichter Syndrome
Start date
2019-07-10
Primary completion
2026-11-04
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.